{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:7ad39d22-85e1-4628-b5fa-047dae9ac718","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-22T14:53:57.133898+00:00","published_at":"2026-10-22T04:46:58.514434+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1f5v7j41ly4ls4","event_type":"DIRECTOR_APPOINTED","effective_at":"2026-07-28","detected_at":"2026-10-22T04:46:58.514434+00:00","subject_ids":["alpha:person:matthew-pratt-whalen-telo","alpha:company:7ad39d22-85e1-4628-b5fa-047dae9ac718"],"caused_claim_ids":["alpha:claim:company:7ad39d22-85e1-4628-b5fa-047dae9ac718:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:7c11ed1f135d20db6b037e1e4595dceb52087d05a8127b09e734aa7a24308eb0"],"summary":"Matthew Pratt Whalen seat on Telomir Pharmaceuticals, Inc., effective 2026-07-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yh2hee137u4iy","event_type":"CFO_CHANGED","effective_at":"2026-03-17","detected_at":"2026-10-22T04:46:58.514434+00:00","subject_ids":["alpha:person:alan-weichselbaum","alpha:company:7ad39d22-85e1-4628-b5fa-047dae9ac718"],"caused_claim_ids":["alpha:claim:company:7ad39d22-85e1-4628-b5fa-047dae9ac718:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:32543cadb74ee14392d5dd9d986605764e11deeef26ebe90372891dcaf8c481a"],"summary":"Alan Weichselbaum executive of Telomir Pharmaceuticals, Inc., effective 2026-03-17.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:7ad39d22-85e1-4628-b5fa-047dae9ac718:leadership_role:8","subject_id":"alpha:company:7ad39d22-85e1-4628-b5fa-047dae9ac718","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-pratt-whalen-telo","object_label":"Matthew Pratt Whalen","object_source_name_forms":[],"value":"Matthew Pratt Whalen: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:matthew-pratt-whalen-telo","name":"Matthew Pratt Whalen"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-07-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-07-28","valid_to":null,"recorded_at":"2026-10-22T04:46:58.514434+00:00","sources":[{"id":"alpha:projection-evidence:document:7c11ed1f135d20db6b037e1e4595dceb52087d05a8127b09e734aa7a24308eb0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Telomir Pharmaceuticals, Inc. DEF 14A 2026-07-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm","source_date":"2026-07-28T21:00:01+00:00","retrieved_at":"2026-09-14T01:53:02.756+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-07-28T21:00:01+00:00","effective_from":"2026-07-28","effective_until":null,"observed_at":"2026-10-22T04:46:58.514434+00:00","reviewed_at":"2026-10-22T04:46:58.514434+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7ad39d22-85e1-4628-b5fa-047dae9ac718:leadership_role:9","subject_id":"alpha:company:7ad39d22-85e1-4628-b5fa-047dae9ac718","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alan-weichselbaum","object_label":"Alan Weichselbaum","object_source_name_forms":[],"value":"Alan Weichselbaum: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alan-weichselbaum","name":"Alan Weichselbaum"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-17","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-17","valid_to":null,"recorded_at":"2026-10-22T04:46:58.514434+00:00","sources":[{"id":"alpha:projection-evidence:document:32543cadb74ee14392d5dd9d986605764e11deeef26ebe90372891dcaf8c481a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TELO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226010625/form10-k.htm","source_date":"2026-03-17T00:00:00+00:00","retrieved_at":"2026-05-16T09:03:30.99339+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-17T00:00:00+00:00","effective_from":"2026-03-17","effective_until":null,"observed_at":"2026-10-22T04:46:58.514434+00:00","reviewed_at":"2026-10-22T04:46:58.514434+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:7c11ed1f135d20db6b037e1e4595dceb52087d05a8127b09e734aa7a24308eb0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Telomir Pharmaceuticals, Inc. DEF 14A 2026-07-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226035026/formdef14a.htm","source_date":"2026-07-28T21:00:01+00:00","retrieved_at":"2026-09-14T01:53:02.756+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:32543cadb74ee14392d5dd9d986605764e11deeef26ebe90372891dcaf8c481a","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TELO 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226010625/form10-k.htm","source_date":"2026-03-17T00:00:00+00:00","retrieved_at":"2026-05-16T09:03:30.99339+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.804,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.764,"cross_source_agreement":0.75,"temporal_completeness":0.286},"diagnostics":{"published_claims":11,"factual_claims":11,"claims_with_linked_evidence":11,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":7,"temporal_claims_with_valid_from":2,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-22T04:46:58.514434+00:00","observed_at":"2026-10-22T04:46:58.514434+00:00","reviewed_at":"2026-10-22T04:46:58.514434+00:00","verified_at":"2026-10-22T04:46:58.514434+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/telomir-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/telomir-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}